과제정보
연구 과제 주관 기관 : National Institute of Health
참고문헌
- Belair, C.D., Yeager, T.R., Lopez, P.M., and Reznikoff, C.A. (1997). Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc. Natl. Acad. Sci. USA 94, 13677-13682 https://doi.org/10.1073/pnas.94.25.13677
- Cahir-McFarland, E.D., Carter, K., Rosenwald, A., Giltnane, J.M., Henrickson, S.E., Staudt, L.M., and Kieff, E. (2004). Role of NF-{kappa}B in cell survival and transcription of latent membrane protein 1-expressing or epstein-Barr virus latency III-infected Cells. J. Virol. 78, 4108-4119 https://doi.org/10.1128/JVI.78.8.4108-4119.2004
- Carter, K.L., Cahir-McFarland, E., and Kieff, E. (2002). Epstein-Barr virus-induced changes in B-lymphocyte gene expression. J. Virol. 76, 10427-10436 https://doi.org/10.1128/JVI.76.20.10427-10436.2002
- Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., and Kieff, E. (2003). EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virustransformed lymphoblast growth. J. Virol. 77, 999-1010 https://doi.org/10.1128/JVI.77.2.999-1010.2003
- Eliopoulos, A.G., and Young, L.S. (2001). LMP1 structure and signal transduction. Semin. Cancer Biol. 11, 435-444 https://doi.org/10.1006/scbi.2001.0410
- Grimm, T., Schneider, S., Naschberger, E., Huber, J., Guenzi, E., Kieser, A., Reitmeir, P., Schulz, T.F., Morris, C.A., and Sturzl, M. (2005). EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 105, 3263-3269 https://doi.org/10.1182/blood-2004-07-2752
- Hahn, W.C. (2002). Immortalization and transformation of human cells. Mol. Cells 13, 351-361
- Hei, T.K., Persaud, R., Zhou, H., and Suzuki, M. (2004) Genotoxicity in eyes of bystander cells. Mutat. Res. 568, 111-120 https://doi.org/10.1016/j.mrfmmm.2004.07.015
- Henkel, T., Ling, P.D., Hayward, S.D., and Peterson M.G. (1994). Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa, Science 265, 92-95 https://doi.org/10.1126/science.8016657
- Hur, D.Y., Lee, M.H., Kim, J.W., Kim, J.H., Shin, Y.K., Rho. J.K., Kwack, K.B., Lee, W.J., and Han, B.G. (2005). CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell. Cell Prolif. 38, 35-45 https://doi.org/10.1111/j.1365-2184.2005.00328.x
- Jeon, J.P., Shim, S.M., Nam, H.Y., Baik, S.Y., Kim. J.W., and Han, B.G. (2007). Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines. Cancer Genet. Cytogenet. 173, 122-130 https://doi.org/10.1016/j.cancergencyto.2006.10.010
- Jeon, J.P., Kim, J.W., Park, B., Nam, H.Y., Shim, S.M., Lee, M.H., and Han, B.G.. (2008) Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation. Acta Virologica 52,151-159
- Johannsen, E., Koh, E., Mosialos, G., Tong, X., Kieff, E., and Grossman, S.R. (1995). Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. J. Virol. 69, 253-262
- Johannsen, E., Miller, C.L., Grossman, S.R., and Kieff, E. (1996). EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70, 4179-4183
- Kamranvar, S.A., Gruhne, B., Szeles, A., and Masucci, M.G. (2007). Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma. Oncogene 26, 5115-5123 https://doi.org/10.1038/sj.onc.1210324
- Kieff, E., and Rickinson, A.B. (2001). In Fields Virology, D.M. Knipe, and P.M. Howley, eds. (Lippincott, Philadelphia, USA). Vol. 2, pp. 2511-2628
- Kilger, E., Kieser, A., Baumann, M., and Hammerschmidt, W. (1998). Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J. 17, 1700-1709 https://doi.org/10.1093/emboj/17.6.1700
- Kim, K.J., Lee, H.J., Park, M.H., Cha, S.H., Kim, K.S., Kim, H.T., Kimm, K., Oh, B., and Lee, J.Y. (2006). SNP identification, linkage disequilibrium, and haplotype analysis for a 200-kb genomic region in a Korean population. Genomics 88, 535-540 https://doi.org/10.1016/j.ygeno.2006.03.003
- Liu, J.P., Cassar, L., Pinto, A., and Li, H. (2006). Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Cell Res. 16, 809-817 https://doi.org/10.1038/sj.cr.7310098
- McClain, K., Estrov, Z., Raju, U., Kelley, P.K., and Aggarwal, B.B. (1997). Epstein-Barr virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes. Methods 11, 83-87 https://doi.org/10.1006/meth.1996.0391
- Mei, Y.P., Zhu, X.F., Zhou, J.M., Huang, H., Deng, R., and Zeng, Y.X. (2006). siRNA targeting LMP1-induced apoptosis in EBVpositive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Lett. 232, 189-198 https://doi.org/10.1016/j.canlet.2005.02.010
- Mochida, A., Gotoh, E., Senpuku, H., Harada, S., Kitamura, R., Takahashi, T., and Yanagi, K. (2005). Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBVnegative Burkitt's lymphoma cell lines. Arch. Virol. 150, 2139-2150 https://doi.org/10.1007/s00705-005-0557-2
- Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., et al. (2006). Global variation in copy number in the human genome. Nature 444, 444-454 https://doi.org/10.1038/nature05329
- Robertson, E.S., Lin, J., and Kieff, E. (1996). The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J. Virol. 70, 3068-3074
- Rodriguez-Revenga, L., Mila, M., Rosenberg, C., Lamb, A., and Lee, C. (2007). Structural variation in the human genome: the impact of copy number variants on clinical diagnosis. Genet. Med. 9, 600-606 https://doi.org/10.1097/GIM.0b013e318149e1e3
-
Saito, N., Courtois, G., Chiba, A., Yamamoto, N., Nitta, T., Hironaka, N., Rowe, M., Yamamoto, N., and Yamaoka, S. (2003). Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-
$_{\kappa}$ B through distinct signaling pathways in fibroblast cell lines. J. Biol. Chem. 278, 46565-46575 https://doi.org/10.1074/jbc.M302549200 - Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., and Takada, K. (1994). Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J. Virol. 68, 6069-6073
- Spender, L.C., Cornish, G.H., Sullivan, A., and Farrell, P.J. (2002). Expression of transcription factor AML-2 (RUNX3, CBFalpha-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J. Virol. 76, 4919-4927 https://doi.org/10.1128/JVI.76.10.4919-4927.2002
- Srinivas, S.K., and Sixbey, J.W. (1995). Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J. Virol. 69, 8155-8158
- Sugimoto, M., Furuichi, Y., Ide, T., and Goto, M. (1999). Incorrect us of 'immortalization' for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J. Virol. 73, 9690-9691
- Sugimoto, M., Tahara, H., Ide, T., and Furuichi, Y. (2004). Steps involved in immortalization and tumorigenesis in human Blymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Res. 64, 3361-3364 https://doi.org/10.1158/0008-5472.CAN-04-0079
- Sylla, B.S., Hung, S.C., Davidson, D.M., Hatzivassiliou, E., Malinin, N.L., Wallach, D., Gilmore, T.D., Kieff, E., and Mosialos, G. (1998). Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc. Natl. Acad. Sci. USA 95, 10106-10111 https://doi.org/10.1073/pnas.95.17.10106
- Toda, T., and Sugimoto, M. (2003). Proteome analysis of Epstein- Barr virus-transformed B-lymphoblasts and the proteome database. J. Chromatography B. 787, 197-206 https://doi.org/10.1016/S1570-0232(02)00495-6
- Yoo, Y.K., Ke, X., Hong, S., Jang, H.Y., Park, K., Kim, S., Ahn, T., Lee, Y.D., Song, O., Rho, N.Y., et al. (2006). Fine-scale map of encyclopedia of DNA elements regions in the Korean population. Genetics 174, 491-497 https://doi.org/10.1534/genetics.105.052225
- Young, L.S., and Rickinson, A.B. (2004). Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768 https://doi.org/10.1038/nrc1452
- Zhang, L., Hong, K., Zhang, J., and Pagano, J.S. (2004). Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology 323, 141-152 https://doi.org/10.1016/j.virol.2004.03.007
- Zhao, B., Maruo, S., Cooper, A., Chase, M.R., Johannsen, E., Kieff, E., and Cahir-McFarland, E. (2006). RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. USA 103, 1900-1905 https://doi.org/10.1073/pnas.0510612103
피인용 문헌
- Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance vol.43, pp.4, 2009, https://doi.org/10.1111/j.1365-2184.2010.00687.x
- Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma vol.32, pp.2, 2009, https://doi.org/10.1007/s10059-011-0066-y
- Human lymphoblastoid cell lines: a goldmine for the biobankomics era vol.12, pp.6, 2009, https://doi.org/10.2217/pgs.11.24
- MicroRNA signatures associated with immortalization of EBV‐transformed lymphoblastoid cell lines and their clinical traits vol.44, pp.1, 2011, https://doi.org/10.1111/j.1365-2184.2010.00717.x
- National Biobank of Korea: Quality control Programs of Collected-human Biospecimens vol.3, pp.3, 2009, https://doi.org/10.1016/j.phrp.2012.07.007
- Genotype instability during long-term subculture of lymphoblastoid cell lines vol.58, pp.1, 2009, https://doi.org/10.1038/jhg.2012.123
- hTERT Inhibition Triggers Epstein–Barr Virus Lytic Cycle and Apoptosis in Immortalized and Transformed B Cells: A Basis for New Therapies vol.19, pp.8, 2009, https://doi.org/10.1158/1078-0432.ccr-12-2537
- Epstein-Barr virus and telomerase: from cell immortalization to therapy vol.9, pp.1, 2009, https://doi.org/10.1186/1750-9378-9-8
- Genetic factors underlying discordance in chromatin accessibility between monozygotic twins vol.15, pp.5, 2014, https://doi.org/10.1186/gb-2014-15-5-r72
- Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus vol.6, pp.None, 2015, https://doi.org/10.1038/cddis.2015.145
- Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells vol.10, pp.4, 2009, https://doi.org/10.1371/journal.pone.0123645
- Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group vol.14, pp.5, 2016, https://doi.org/10.1089/bio.2016.0018
- Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization vol.9, pp.8, 2009, https://doi.org/10.3390/v9080217
- Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications vol.13, pp.1, 2018, https://doi.org/10.1186/s13027-018-0186-5
- Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease vol.26, pp.9, 2009, https://doi.org/10.1093/ibd/izaa065
- The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis vol.10, pp.None, 2009, https://doi.org/10.1038/s41598-019-55850-z